152 related articles for article (PubMed ID: 30189238)
1. GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice.
Wang YH; Liou KT; Tsai KC; Liu HK; Yang LM; Chern CM; Shen YC
Toxicol Appl Pharmacol; 2018 Oct; 357():88-105. PubMed ID: 30189238
[TBL] [Abstract][Full Text] [Related]
2. The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke.
Loris ZB; Pieper AA; Dietrich WD
Exp Neurol; 2017 Apr; 290():63-73. PubMed ID: 28077334
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxystypandrone ameliorates brain function through preserving BBB integrity and promoting neurogenesis in mice with acute ischemic stroke.
Chern CM; Wang YH; Liou KT; Hou YC; Chen CC; Shen YC
Biochem Pharmacol; 2014 Feb; 87(3):502-14. PubMed ID: 24342702
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke.
Wang SN; Xu TY; Wang X; Guan YF; Zhang SL; Wang P; Miao CY
CNS Neurosci Ther; 2016 Sep; 22(9):782-8. PubMed ID: 27333812
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid A alleviates ischemic brain injury through the inhibition of inflammation and apoptosis and the promotion of neurogenesis in mice.
Chien MY; Chuang CH; Chern CM; Liou KT; Liu DZ; Hou YC; Shen YC
Free Radic Biol Med; 2016 Oct; 99():508-519. PubMed ID: 27609227
[TBL] [Abstract][Full Text] [Related]
6. Ergostatrien-7,9(11),22-trien-3β-ol from Antrodia camphorata ameliorates ischemic stroke brain injury via downregulation of p65NF-κ-B and caspase 3, and activation of Akt/GSK3/catenin-associated neurogenesis.
Wang YH; Chern CM; Liou KT; Kuo YH; Shen YC
Food Funct; 2019 Aug; 10(8):4725-4738. PubMed ID: 31304955
[TBL] [Abstract][Full Text] [Related]
7. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
Chen F; Wang W; Ding H; Yang Q; Dong Q; Cui M
J Neuroinflammation; 2016 Aug; 13(1):204. PubMed ID: 27566245
[TBL] [Abstract][Full Text] [Related]
8. An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.
Zhang H; Liu Y; Guan S; Qu D; Wang L; Wang X; Li X; Zhou S; Zhou Y; Wang N; Meng J; Ma X
PLoS One; 2016; 11(2):e0148827. PubMed ID: 26863436
[TBL] [Abstract][Full Text] [Related]
9. Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways.
Abdel-Latif RG; Heeba GH; Taye A; Khalifa MMA
Eur J Pharmacol; 2018 Aug; 833():145-154. PubMed ID: 29864411
[TBL] [Abstract][Full Text] [Related]
10. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats.
Loris ZB; Hynton JR; Pieper AA; Dietrich WD
Transl Stroke Res; 2018 Apr; 9(2):146-156. PubMed ID: 28842830
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Long Non-Coding RNA LINC00652 Restores Sevoflurane-Induced Cardioprotection Against Myocardial Ischemia-Reperfusion Injury by Targeting GLP-1R Through the cAMP/PKA Pathway in Mice.
Zhang SB; Liu TJ; Pu GH; Li BY; Gao XZ; Han XL
Cell Physiol Biochem; 2018; 49(4):1476-1491. PubMed ID: 30205407
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia.
Lee CH; Yan B; Yoo KY; Choi JH; Kwon SH; Her S; Sohn Y; Hwang IK; Cho JH; Kim YM; Won MH
J Neurosci Res; 2011 Jul; 89(7):1103-13. PubMed ID: 21472764
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective Effects of 1-(3,6-Dibromo-carbazol-9-yl)-3-Phenylamino-Propan-2-Ol in Diabetic Hearts via Nicotinamide Phosphoribosyltransferase Activation.
Tur J; Badole SL; Manickam R; Chapalamadugu KC; Xuan W; Guida W; Crews JJ; Bisht KS; Tipparaju SM
J Pharmacol Exp Ther; 2022 Aug; 382(2):233-245. PubMed ID: 35680376
[TBL] [Abstract][Full Text] [Related]
15. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
Yang H; Li H; Wang Z; Shi Y; Jiang G; Zeng F
J Surg Res; 2013 Dec; 185(2):825-32. PubMed ID: 23890403
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injury.
Zhang QH; Hao JW; Li GL; Ji XJ; Yao XD; Dong N; Yao YM
Inflamm Res; 2018 Feb; 67(2):157-168. PubMed ID: 29022064
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
Hou Y; Ernst SA; Heidenreich K; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner.
Khedr RM; Ahmed AAE; Kamel R; Raafat EM
Life Sci; 2018 Oct; 211():31-39. PubMed ID: 30195035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]